Journals / Arşiv Kaynak Tarama Dergisi / 2020 / Cilt: 29 - Sayı: 2

Approach to Adverse Drug Reactions

Advers İlaç Reaksiyonlarına Yaklaşım

Pages
97–107
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, types of adverse drug reactions, principles regarding causality assessment and basic treatment approaches are outlined.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Healthcare professionals, contrary to what is known, more frequently encounter adverse drug reactions during clinical practice.
📊
Key Findings & Data:Irrespective from spontaneous reporting of pharmacovigilance system, these professionals, particularly physicians, should solve these problems immediately.
💡
Conclusion & Impact:In this review, types of adverse drug reactions, principles regarding causality assessment and basic treatment approaches are outlined.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Healthcare professionals, contrary to what is known, more frequently encounter adverse drug reactions during clinical practice. Irrespective from spontaneous reporting of pharmacovigilance system, these professionals, particularly physicians, should solve these problems immediately. However, at first they have to evaluate the causal relationship between adverse events and drugs and then initiate the necessary therapeutic interventions. If physicians ignore the potential roles of medications in the etiology of complaints of patients and instead prescribe new drugs towards new treatment goals, new adverse events would be unavoidable. Therefore, the presence of adverse drug reactions should always be questioned correctly and, if necessary, the patient's well-being should be ensured by essential changes in the treatment protocol. In this review, types of adverse drug reactions, principles regarding causality assessment and basic treatment approaches are outlined.

Özet

Sağlık profesyonelleri advers ilaç reaksiyonları ile, bilinenin aksine, klinik pratikte daha sık karşılaşmaktadır.Farmakovijilans sisteminin spontan bildiriminden bağımsız olarak, bu profesyoneller, özellikle hekimler, bu problemlerihızlı bir şekilde çözmelidirler. Ancak, ilk önce advers olaylar ile ilaçlar arasındaki nedensellik ilişkisini değerlendirmelerigerekmektedir ve daha sonra gerekli tedavi girişimleri başlatmalıdırlar. Hekimler ilaçların hastaların şikâyetlerindeki olasırollerini görmezden gelip yeni tedavi hedeflerine yönelik daha fazla ilaç yazma yoluna giderlerse, yeni advers olaylarınoluşması kaçınılmaz olacaktır. Bu nedenle advers ilaç reaksiyonlarının varlığı her zaman doğru bir şekilde sorgulanmalıve gerektiğinde tedavi protokolündeki değişikliklerle hastanın esenliği sağlanmalıdır. Bu derlemede advers ilaçreaksiyonlarının tipleri, nedensellik analizi ile ilişkili prensipler ve temel tedavi yaklaşımları özetlenmiştir.

🔖

Cite This Article

AYKAN, D. A., ERGÜN, Y. (2022). Approach to Adverse Drug Reactions. Arşiv Kaynak Tarama Dergisi, Cilt: 29 - Sayı: 2, 97–107. https://ajindex.com/articles/449105

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Aydınkarahaliloğlu ND, Kayaalp O. Farmakovijilans. In Klinik Farmakolojinin Esasları, 4üncü baskı (ed Kayaalp SO): Ankara, Pelikan Yayıncılık. 2008;287-342. World Health Organization: Safety of medicines: A guide to detecting and reporting adverse drug reactions-why health professionals need to take action. Geneva. 2002. Uppsala Monitoring Centre. Available from: https://www.who-umc.org/. Accessed: 10 March 2019.
  2. Ergün Y, Ergün TB, Toker E, Ünal E, Akben M. Knowledge attitude and practice of Turkish health professionals towards pharmacovigilance in a university hospital. Int Health. 2019;11:177-184.
  3. Kongkaew C, Noyce PR, Ashcroft DM. Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies. Ann Pharmacother. 2008;42:1017-25.
  4. Lundkvist J, Jönsson B. Pharmacoeconomics of adverse drug reactions. Fundam Clin Pharmacol. 2004;18:275-80.
  5. Pirmohamed M, Breckenridge AM, Kitteringham NR, Park BK. Adverse drug reactions. BMJ. 1998; 316:1295-8. İlaçların Güvenliliği Hakkında Yönetmelik. Resmî gazete: 15.04.2014/28973. Fotis M, Budris W. Clinical Analysis of Adverse Drug Reactions. In Principles of Clinical Pharmacology, 3rd ed (eds Atkinson AJ, Huang S-M, Lertora JJL, Markey SP): UK, Academic Press Elsevier. 2012;395-416. Kaufman G. Adverse drug reactions: classification, susceptibility and reporting. Nurs Stand. 2016 Aug 10;30(50):53-63. doi: 10.7748/ns.2016.e10214. Pirmohamed M, Park BK. Genetic susceptibility to adverse drug reactions. Trends Pharmacol Sci. 2001;22:298-305.
  6. Schatz SN, Weber RJ. Adverse Drug Reactions. PSAP 2015 CNS/Pharmacy Practice. Daly AK. Pharmacogenomics of adverse drug reactions. Genome Med. 2013;5:5. doi: 10.1186/gm409. Ma JD, Lee KC, Kuo GM. HLA-B*5701 testing to predict abacavir hypersensitivity. PLoS Curr. 2010; Dec 7;2:RRN1203. doi: 10.1371/currents.RRN1203. Beach SR, Celano CM, Sugrue AM, Adams C, Ackerman MJ, Noseworthy PA, et al. QT Prolongation, Torsades de Pointes, and Psychotropic Medications: A 5-Year Update. Psychosomatics. 2018;59:105-122. doi:10.1016/j.psym.2017.10.009. Kayaalp SO, Akıcı A. İlaçların toksik tesirleri ve toksikolojinin temel kavramları. In Akılcıl Tedavi Yönünden Tıbbi Farmakoloji. 13üncü baskı (ed Kayaalp SO): Ankara, Pelikan Yayıncılık. 2012;114-122.
  7. Gurgle HE, Blumenthal DK. Drug Therapy for Dyslipidemias. In Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th ed (eds Brunton LL, Hilal-Dandan R, Knollmanl BC): location US, McGraw-Hil